AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Clinical Multimodal Surveillance of Respiratory Syndrome Pathogens

Recruitingn/aAges any - anyAllHuashan Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This nationwide, multicenter observational study will establish and improve a hospital-based clinical surveillance and early warning system for respiratory syndrome pathogens. Clinical data and biospecimens generated during routine care will be collected from participating medical institutions every two weeks to monitor pathogen trends, support risk assessment, and provide evidence for prevention and control measures.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Patients with respiratory syndrome: Eligible patients are those diagnosed with respiratory syndrome based on the predefined data dictionary and the following ICD-10 (International Statistical Classification of Diseases, 10th Revision) diagnosis codes: R05, R50, J00, J01, J02, J03, J04, J06, J07, J08, J09, J10, J11, J12, J13, J14, J15, J16, J17, J18, J20, J21, J98.414, and J98.802. * Patients with respiratory syndrome: Eligible patients are identified using the following search criteria. Patients meeting any one of the following criteria should be included: 1. Medical history (History of Present Illness): Positive test result for a respiratory syndrome-related pathogen. 2. Laboratory testing: Positive test result for a respiratory syndrome-related pathogen. 3. Medication: Receipt of any of the following antiviral agents: Nirmatrelvir/Ritonavir Leritrelvir Xiannuotewei/Ritonavir Molnupiravir Azvudine Deuremidevir 4. Diagnosis: Diagnosis containing the term "respiratory tract infection." Exclusion Criteria: * Participants who may compromise the study results: Patients who are unable to provide a specimen or whose specimen volume is insufficient for laboratory testing. * Participants who are unable to comply with study procedures.
๐Ÿ’Š

What it tests

  • Tiered pathogen testing and multi-omics analysis
๐Ÿ“

Where

31 sites
Beijing You'an Hospital, Capital Medical University
Beijing, China
The Fifth Affiliated Hospital of Guangzhou Medical University
Guangzhou, China
The Fifth Affiliated Hospital of Sun Yat-sen University
Zhuhai, China
The 980th Hospital of the People's Liberation Army Joint Logistics Support Force
Shijiazhuang, China
Heilongjiang Provincial Hospital
Harbin, China
Jiamusi Central Hospital
Jiamusi, China
Shangqiu Municipal Hospital
Shangqiu, China
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, China

โ€ฆand 23 more on ClinicalTrials.gov.

๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy